CRABP2 and cancer: Resistance to retinoids has been observed in certain PDAC cell lines, as well as other types of cancer, and may be associated with a deficiency in the cellular retinoic acid-binding protein 2 (CRABP2) [55, 59], which is involved in the intracellular transport of retinoic acid [60–62].